Prevalence, determinants and clinical correlates of vitamin D deficiency in patients with Chronic Obstructive Pulmonary Disease in London, UK

[1]  David A. Jolliffe,et al.  Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies , 2016, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  Y. Slavova,et al.  Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients , 2015, PloS one.

[3]  David A. Jolliffe,et al.  Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs) , 2015, Thorax.

[4]  David A. Jolliffe,et al.  Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.

[5]  M. Touvier,et al.  Determinants of vitamin D status in Caucasian adults: influence of sun exposure, dietary intake, sociodemographic, lifestyle, anthropometric, and genetic factors. , 2015, The Journal of investigative dermatology.

[6]  E. Ozyilmaz,et al.  The effect of Vitamin D deficiency on lung function in current smoker COPD patients , 2014 .

[7]  E. Wouters,et al.  Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease , 2013, Annals of medicine.

[8]  M. Decramer,et al.  Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial , 2012, Respiratory Research.

[9]  P. Bakke,et al.  Chronic Obstructive Pulmonary Disease Is Associated with Low Levels of Vitamin D , 2012, PloS one.

[10]  M. Polkey,et al.  Vitamin D and skeletal muscle strength and endurance in COPD , 2012, European Respiratory Journal.

[11]  M. Decramer,et al.  High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2012 .

[12]  D. Postma,et al.  Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD. , 2011, Respiratory medicine.

[13]  Daniel L. Koller,et al.  Common genetic determinants of vitamin D insufficiency: a genome-wide association study , 2010, The Lancet.

[14]  M. Decramer,et al.  Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene , 2009, Thorax.

[15]  E. Hyppönen,et al.  Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. , 2007, The American journal of clinical nutrition.

[16]  V. Backer,et al.  The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. , 2007, Respiratory medicine.

[17]  C. Brightling,et al.  Eosinophilic airway inflammation in COPD , 2006, International journal of chronic obstructive pulmonary disease.

[18]  J. Hankinson,et al.  Standardisation of spirometry , 2005, European Respiratory Journal.

[19]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[20]  P. Jones.  St. George's Respiratory Questionnaire: MCID , 2005, COPD.

[21]  P. Barnes.  Mediators of Chronic Obstructive Pulmonary Disease , 2004, Pharmacological Reviews.

[22]  M. Vatn,et al.  Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease , 2004, Journal of internal medicine.

[23]  Ons,et al.  The National Statistics Socio-economic Classification User Manual , 2002 .

[24]  J L Hankinson,et al.  Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.

[25]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[26]  M. Jeanmougin.  SOLEIL ET PEAU , 1992 .